相似文献
1
[Immunologic analysis of dibekacin in human serum: comparison of 4 methods].
J Pharm Belg. 1983 Mar-Apr;38(2):69-75.
2
Quantitative determination of dibekacin using radioimmunoassay, substrate-labelled fluorescent immunoassay and rate nephelometric inhibition immunoassay for tobramycin.
Ann Inst Pasteur Microbiol (1985). 1985 May-Jun;136A(3):381-8. doi: 10.1016/s0769-2609(85)80100-9.
3
Rapid method for determination of kanamycin and dibekacin in serum by use of high-pressure liquid chromatography.
Antimicrob Agents Chemother. 1985 Oct;28(4):521-3. doi: 10.1128/AAC.28.4.521.
4
Substrate-labeled fluorescent immunoassay for measuring dibekacin concentrations in serum and plasma.
Antimicrob Agents Chemother. 1983 Aug;24(2):240-5. doi: 10.1128/AAC.24.2.240.
5
[Plasma level of dibekacin in children with mucoviscidosis. Comparison with a control population].
Ann Pediatr (Paris). 1987 Nov;34(9):713-7.
6
[Bone levels of dibekacin].
Pathol Biol (Paris). 1984 May;32(5):343-6.
7
Pharmacodynamics and pharmacokinetics of dibekacin in the neonate--comparison between the intramuscular and intravenous routes.
Dev Pharmacol Ther. 1984;7 Suppl 1:121-4. doi: 10.1159/000457240.
8
[Dibekacin blood concentration following intravenous drip infusion (author's transl)].
Jpn J Antibiot. 1979 May;32(5):624-6.
9
[Blood levels of dibekacin following intravenous drip infusion (author's transl)].
Jpn J Antibiot. 1977 Sep;30(9):667-71.
10
[Plasma levels of dibekacin (DKB) following bronchial lavage using bronchofiberscope and nebulized aerosol administration via IPPB (author's transl)].
Nihon Kyobu Shikkan Gakkai Zasshi. 1979 May;17(5):273-9.
Zotero 插件